Journal article Open Access

Resistance to ceftaroline - 2018 review

Ślusarczyk, Rafał; Bielejewska, Ada; Bociek, Arkadiusz; Bociek, Martyna

Ceftaroline is a new fifth generation cephalosporin, active mostly against Gram-positive cocci, e.g. Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus). It is used in treating acute bacterial skin and skin structure infections, community acquired respiratory tract infections and methicillin-resistant S. aureus bacteremia. The main resistance mechanisms of bacteria to β-lactam antibiotics, including ceftaroline, are mutations in PBP2a, PBP3 and PBP4. Clinically significant resistance has been noted among both archived and newly-isolated strains in a laboratory test using serial passages. Ceftaroline-resistant strains have also been found in patients suffering from cystic fibrosis, ventilator-associated pneumonia and infectious endocarditis. Irresponsible antibiotic treatment using ceftaroline or other antibiotics (due to a possibility of a cross-resistance) can lead to the spread of ceftaroline resistance and, consequently, its loss of value.

Files (141.0 kB)
Name Size
141.0 kB Download
All versions This version
Views 55
Downloads 33
Data volume 423.1 kB423.1 kB
Unique views 55
Unique downloads 33


Cite as